Acute diffuse and transient thyroid swelling after intravenous thrombolysis for acute ischemic stroke: A case report

Medicine (Baltimore). 2018 Sep;97(36):e12149. doi: 10.1097/MD.0000000000012149.

Abstract

Rationale: Intravenous thrombolysis is the primary therapy for acute ischemic stroke (AIS), but it has some complications, including symptomatic intracranial hemorrhage, orolingual angioedema, and extracranial bleeding. However, thyroid disorders associated with thrombolysis are very rare.

Patient concerns: A 56-year-old man developed acute pain and neck swelling after thrombolysis with recombinant tissue plasminogen activator.

Diagnoses: Ultrasound revealed a diffusely enlarged thyroid with linear hypoechoic areas throughout the entire gland, resembling a "cracked" appearance.

Interventions: The patient was treated conservatively with cold packs and observed closely. Follow-up ultrasound was made.

Outcomes: A few hours later, pain and swelling disappeared completely. A repeat ultrasound revealed complete recovery of thyroid volume and aspect on the next day.

Lessons: After intravenous thrombolysis for AIS, several life-threatening complications, such as hemorrhage and orolingual angiedema, also can cause neck swelling. Urgent intubation and surgery may be required. However, the rare complication, acute diffuse thyroid swelling, is self-limiting and nonfatal and conservative treatment is sufficient. Neck ultrasound is helpful in rapidly distinguishing these complications.

Publication types

  • Case Reports

MeSH terms

  • Administration, Intravenous
  • Brain Ischemia / drug therapy
  • Diagnosis, Differential
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Recombinant Proteins / administration & dosage
  • Stroke / drug therapy
  • Thrombolytic Therapy / adverse effects*
  • Thyroid Diseases / diagnostic imaging
  • Thyroid Diseases / etiology*
  • Thyroid Diseases / therapy
  • Thyroid Gland / diagnostic imaging
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / adverse effects*

Substances

  • Fibrinolytic Agents
  • Recombinant Proteins
  • Tissue Plasminogen Activator